Quality assessment in prospective nuchal translucency screening for Down syndrome

被引:50
作者
Wojdemann, KR
Christiansen, M
Sundberg, K
Larsen, SO
Shalmi, A
Tabor, A
机构
[1] Copenhagen Univ Hosp, Dept Obstet & Gynaecol, Hvidovre Hosp, DK-2650 Hvidovre, Denmark
[2] State Serum Inst, Dept Clin Biochem, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Dept Obstet Ultrasound, Copenhagen, Denmark
关键词
image scoring; prenatal screening; quality control; trisomy; 21;
D O I
10.1046/j.0960-7692.2001.00592.x
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objectives To develop and apply a quality control system in a Down syndrome screening study using nuchal translucency as an interventional marker. Methods In a prospective Down syndrome screening study fetal nuchal translucency thickness Was measured in 9236 of the 10045 examined pregnancies. For quality assessment two models were introduced: firstly, image-scoring evaluation of The nuchal translucency thickness measurements and secondly, establishment of The distributions of nuchal translucency multiples of the median over time and the influence of intervention. Results The observer variability in the image-scoring evaluation was high with a kappa value of 0.48 in the overall validation. A revised model showed better interobserver agreement with a kappa value of 0.58; however, comparing the individual criteria the differences were still unsatisfactory, i.e. we found highly significant differences in the criteria 'position of the fetus' (P = 0.0026) and magnification of the image' (P = 0.0001). Regarding the distributions of the nuchal translucency multiples of the median, the median stabilized after a short learning phase representing the practical part of the sonographer's certification to nuchal translucency screening. In groups of medians of SO nuchal translucency multiples of the median the intergroup standard deviation decreased from 0.100-0.060 after the learning phase to 0.046 after intervention. Conclusions When well-trained certified examiners perform nuchal translucency screening, continuous evaluation of the distribution of The nuchal translucency multiples of the median seems to be a good method to assess the quality fur a center and may also be used to identify individual examiners deviating front the mean performance. The image-scoring methods we introduced cannot be recommended for quality control in a nuchal translucency screening program.
引用
收藏
页码:641 / 644
页数:4
相关论文
共 50 条
[41]   Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies [J].
Sepulveda, W. ;
Wong, A. E. ;
Casasbuenas, A. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 33 (02) :152-156
[42]   Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis [J].
Wald, Nicholas J. ;
Morris, Joan K. ;
Walker, Kate ;
Simpson, John M. .
PRENATAL DIAGNOSIS, 2008, 28 (12) :1094-1104
[43]   Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation [J].
Jouannic, Jean-Marie ;
Thieulin, Anne-Claire ;
Bonnet, Damien ;
Houyel, Lucile ;
Lelong, Nathalie ;
Goffinet, Francois ;
Khoshnood, Babak .
PRENATAL DIAGNOSIS, 2011, 31 (13) :1264-1269
[44]   Analysis of External Quality Assessment of Maternal Serum Prenatal Screening for Down Syndrome in the First Trimester in China [J].
He, Falin ;
Wang, Wei ;
Zhong, Kun ;
Yuan, Shuai ;
Du, Yuxuan ;
Wang, Zhiguo .
CLINICAL LABORATORY, 2021, 67 (06) :1357-1364
[45]   A prospective two years study of first trimester screening for Down Syndrome [J].
Zournatzi, V ;
Daniilidis, A. ;
Karidas, C. ;
Tantanasis, T. ;
Loufopoulos, A. ;
Tzafettas, J. .
HIPPOKRATIA, 2008, 12 (01) :28-32
[46]   Quality of patient information leaflets for Down syndrome screening: A comparison between the UK and Thailand [J].
Saiklang, Parvinee ;
Skirton, Heather .
NURSING & HEALTH SCIENCES, 2015, 17 (03) :313-322
[47]   On screening for Down syndrome [J].
van Lith, JMM .
Gynaecology, Obstetrics, and Reproductive Medicine in Daily Practice, 2005, 1279 :221-224
[48]   First-TrimesterNonvisualization of the Parotid Gland and Aneuploidy in Fetuses With Increased Nuchal Translucency A Prospective Cohort Study [J].
Perlman, Sharon ;
Sukenik-Helevy, Rivka ;
Odeh, Marwan ;
Gilat, Efrat Keren ;
Gilboa, Yinon .
JOURNAL OF ULTRASOUND IN MEDICINE, 2021, 40 (01) :41-47
[49]   Screening for trisomy 21 by fetal nuchal translucency and maternal age:: a multicenter project in Germany, Austria and Switzerland [J].
Gasiorek-Wiens, A ;
Tercanli, S ;
Kozlowski, P ;
Kossakiewicz, A ;
Minderer, S ;
Meyberg, H ;
Kamin, G ;
Germer, U ;
Bielicki, M ;
Hackelöer, BJ ;
Sarlay, D ;
Kuhn, P ;
Klapp, J ;
Bahlmann, F ;
Pruggmayer, M ;
Schneider, KTM ;
Seefried, W ;
Fritzer, E ;
Von Kaisenberg, CS .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) :645-648
[50]   Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies [J].
Zoppi, MA ;
Ibba, RM ;
Axiana, C ;
Floris, M ;
Manca, F ;
Monni, G .
PRENATAL DIAGNOSIS, 2003, 23 (06) :496-500